This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at MayoClinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patientcare.
“The term ‘pharmacist-led care’ or ‘pharmacist-led interventions’ refers to health care services where pharmacists play a leading or central role in patientcare,” they continued. 1 “These concepts cover a wide range of activities involving pharmacists directly in clinicalpatientcare across various settings.”
TRE-515 aims to extend patient lives and elevate current standards of care by combining radioligand therapy with novel drug approaches. SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patientcare. MayoClinic.
This approval expanded access to the medication and allowed health care providers to determine if at-home administration is appropriate for the patient. 3 READ MORE: Autoimmune Diseases Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patientcare tips?
1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patientcare, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy.
1 READ MORE: COVID-19 Resource Center Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patientcare tips delivered straight to your inbox. MayoClinic. References 1. Ogungbe O, Wang T, Balte PP, et al. JAMA Netw Open. 2025;8(7):e2520360.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content